-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: embryonic stem cells
CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Aileen Anderson, Dr. Stephen Huhn, embryonic stem cells, locomotion, Martin McGlynn, motor function, neurite growth, paralysis, regeneration, spinal cord injury, spinal cord injury research, stem cell therapy, StemCells Inc, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis
Comments Off on CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD, Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged advocacy, Aileen Anderson PhD, axon regeneration, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, Dr. Jonathon Thomas, embryonic stem cells, motor function, neurite growth, paralysis, regeneration, spinal cord injury research, stem cell biology, stem cells, Stem Cells Inc, StemCells Inc, Stephen Huhn MD, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis, Working 2 Walk 2012
Comments Off on What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
Hans Keirstead, PhD – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Hans Keirstead, PhD. Professor of Anatomy & Neurobiology, Professor of Neurological Surgery, RIRC “Stem-Cell Based Approaches to Treat Spinal Cord Injury” … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged advocacy, astrocytes, axon regeneration, California Stem Cells, chronic spinal cord injury, CIRM, clinical trials, embryonic stem cells, FDA, Geron, IPS cells, lenti virus, locomotion, motor function, motor neuron, mTOR pathway, neurite growth, neurite outgrowth, NIH, PTEN, RIRC, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Hans Keirstead, PhD – Presents at Working 2 Walk 2012
Mark Tuszynski, MD, PhD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Mark Tuszynski, MD, PhD Professor of Neurosciences, Director of the Center for Neural Repair, UC San Diego “Neural Stem Cells for … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, axons, B-tublin, CAP-23, Chondroitinase ABC, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, corticospinal tract, Dr. Mark Tuszynski, embryonic stem cells, ephrin, FDA, GAP-43, growth factors, MAG, myelin, netrin, NeuralStem cells (566RSC-UBQT), neurotrophic support, NIH, Nogo, paralysis, peripheral nerves, proteoglycans, PTEN, regeneration, research, semaphorin, SOCS3, spinal cord injury research, stem cell biology, stem cells, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Mark Tuszynski, MD, PhD. – Presents at Working 2 Walk 2012
Stephen Huhn, MD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Stephen Huhn, MD, FACS, FAAP, Vice President, Head of the CNS Program, Stem Cells, Inc. “Phase I/II Study of Human Neural … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Stephen Huhn, embryonic stem cells, FDA, regeneration, spinal cord injury research, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Stephen Huhn, MD. – Presents at Working 2 Walk 2012
Human iPSC-Derived Neural Stem Cells: Efficacy and Safety Data from a Chronic Cervical Contusion Model of Spinal Cord Injury
Philip Horner, PhD Associate Professor of Neurological Surgery, University of Washington The Andalusian Cellular Reprogramming Laboratory (LARCEL) is a centre belonging to the Ministry of Health of the Regional Andalusian Goverment in the framework of the guidelines of the Andalusian … Continue reading
Posted in Chronic Spinal Cord Injury Research, spinal cord injury research, Stem Cell Research
Tagged academic researchers, axon regeneration, axons, chronic spinal cord injury, Dr. Phil Horner, embryonic stem cells, neurite growth, spinal cord injury research
Comments Off on Human iPSC-Derived Neural Stem Cells: Efficacy and Safety Data from a Chronic Cervical Contusion Model of Spinal Cord Injury
Translation of Stem Cell Based Therapies
Hans Keirstead, PhD Professor of Anatomy & Neurobiology, Neurological Surgery, University of California at Irvine Reeve-Irvine Research Center Additional Information:
Posted in Advocacy, Chronic Spinal Cord Injury Research, Gene Therapy, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, California Stem Cells, chronic spinal cord injury, Dr. Hans Keirstead, embryonic stem cells, FDA, locomotion, motor function, neurite growth, NIH, paralysis, RIRC, stem cells
Comments Off on Translation of Stem Cell Based Therapies
Cell-Based Therapies for SCI: Lessons Learned in Planning and Conducting Two Phase 1 Safety Trials Over the Past 18 Years
Ed Wirth, MD, PhD Spinal Cord Injury Clinical Scientist
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged chronic spinal cord injury, clinical trials, clinical trials spinal cord injury, Dr. Ed Wirth, embryonic stem cells, paralysis, regeneration, RIRC, Roman Reed, stem cell biology, stem cells
Comments Off on Cell-Based Therapies for SCI: Lessons Learned in Planning and Conducting Two Phase 1 Safety Trials Over the Past 18 Years
Innocent Intrigue : Hans S. Keirstead at TEDxOrangeCoast
Stem cells will fundamentally change the course of human disease and longevity, says Hans Keirstead. An internationally known stem cell expert, Hans Keirstead has pioneered stem cell programs at UC Irvine and California Stem Cell. He led his teams to … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Hans Keirstead, embryonic stem cells, motor function, neurite growth, research, RIRC, stem cell biology
Comments Off on Innocent Intrigue : Hans S. Keirstead at TEDxOrangeCoast
UC Irvine Neuroscientist Hans Keirstead, Ph.D.: Stem Cell Research in Spinal Cord Injuries
Hans Keirstead, Ph.D. discusses the potential of stem cells and his efforts to develop new therapies for the more than 1.3 million Americans suffering from spinal cord injuries. Hans Keirstead will be presenting at the Working 2 Walk 2012 Science … Continue reading
Posted in Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, embryonic stem cells, Hans Keirstead, RIRC, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on UC Irvine Neuroscientist Hans Keirstead, Ph.D.: Stem Cell Research in Spinal Cord Injuries
SPINAL CORD INJURY RESEARCH AND SCIENCE 